Friday, 16 October 2026European Markets

ROODMICROTEC Stock Is 20% Up In The Last 10 Sessions

Loading stream...

(VIANEWS) - Shares of ROODMICROTEC (AEX-Index: ROOD.AS) jumped by a staggering 20.54% in 10 sessions from €0.22 to €0.27 at 14:11 EST on Tuesday, after two sequential sessions in a row of gains. AEX-Index is falling 0.67% to €758.19, following the last session's downward trend.

About ROODMICROTEC

RoodMicrotec N.V., together with its subsidiaries, provides semiconductor supply and quality services in the Netherlands and internationally. The company offers supply chain services, wafer and component testing, qualification and reliability investigations, and failure analysis for companies that need application-specific integrated circuits. It also provides supply chain management services comprising engineering support, test engineering, wafer test, assembly, final test, back-end, qualification and reliability support, failure analysis, field return management, and storage and logistics; test engineering services, such as design for test, test time reduction, yield improvement, and data analysis for a range of devices like mixed-signal, digital, analog, and RF ICs; and wafer and component testing that includes wafer testing, component testing, component programming, straightening and scanning, and end of line of the semiconductor device services. In addition, the company offers qualification and failure analysis for the verification of the reliability of electrical and electronic systems and single devices; robustness validation test services; failure analysis of defective devices using physical, chemical, and metallurgical analytical methods; and cross-sectioning services. It serves original equipment manufacturers and fabless companies, as well as others in the automotive, telecommunications, medical, industrial, and electronic sectors. The company was founded in 1969 and is based in Deventer, the Netherlands.

Earnings Per Share

As for profitability, ROODMICROTEC has a trailing twelve months EPS of €0.03.

PE Ratio

ROODMICROTEC has a trailing twelve months price to earnings ratio of 8.93. Meaning, the purchaser of the share is investing €8.93 for every euro of annual earnings.

Volatility

ROODMICROTEC's last week, last month's, and last quarter's current intraday variation average was 1.78%, 0.88%, and 1.78%.

ROODMICROTEC's highest amplitude of average volatility was 2.62% (last week), 2.37% (last month), and 1.78% (last quarter).

More news about ROODMICROTEC (ROOD.AS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com